Trial Profile
A randomized phase II trial of gemcitabine containing regimens (gemcitabine/carboplatin and gemcitabine/cisplatin) when used as preoperative chemotherapy for patients with stage I and II NSCLC
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 29 Sep 2010
Price :
$35
*
At a glance
- Drugs Gemcitabine (Primary) ; Carboplatin; Cisplatin; Paclitaxel
- Indications Non-small cell lung cancer
- Focus Therapeutic Use
- Acronyms GINEST
- Sponsors Eli Lilly and Company
- 03 Aug 2006 Status change
- 10 Dec 2005 New trial record.